M
ast cells are derived from hematopoietic precursors that complete their differentiation and maturation in the microenvironments of almost all vascularized tissues 1 . Mast cells are best known as key effector cells in acute disorders associated with immunoglobulin E (IgE), including anaphylaxis, an immediate and potentially catastrophic systemic response initiated when antigen crosslinks antigen-specific IgE antibodies bound to high-affinity FcεRI receptors on the plasma membrane of mast cells, thereby initiating the activation of mast cells 2 . Mast cells activated by IgE and antigen degranulate (rapidly release preformed, granule-stored bioactive compounds) and also secrete newly formed lipid mediators and a large variety of growth factors, cytokines and chemokines that participate in hypersensitivity reactions 2 . The types and/or amounts of mediators released by mast cells activated by particular signals (including IgE and specific antigen) can be influenced (or 'tuned') by many factors 3 . Among those, the stage of mast cell maturation influences the types and quantities of mediators stored in mast cell cytoplasmic granules and other features of mast cell phenotype 1, 3 . The local development and maturation of mast cells is thought to be regulated by signals provided by structural cells in local tissue microenvironments, such as stemcell factor (SCF) 1, 3 . Indeed, mice with loss-offunction mutations in both copies of the genes encoding SCF or its receptor c-Kit (CD117) are profoundly mast cell deficient, which reflects PLA2G3 promotes mast cell maturation and function
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The mast cell-derived phospholipase PLA2G3 and fibroblast prostaglandin synthase contribute to a mast cell-fibroblast paracrine axis dependent on the prostaglandin PGD 2 and its receptor DP1 that can enhance the maturation and mediator secretion of mast cells.
the importance of SCF and c-Kit in the development and survival of mast cells in vivo 1, 3 . However, understanding of the regulation of mast cell maturation is by no means complete. In this issue of Nature Immunology, Taketomi et al. describe a previously unknown lipidbased mast cell-fibroblast interaction pathway that contributes to the normal maturation of mouse peritoneal, skin and small-intestinal mast cells in vivo 4 . The authors report that the mast cell-secreted phospholipase PLA2G3 has a central role in this maturation mechanism and consequently also enhances the intensity of biological responses involving IgE-dependent activation of mast cells 4 .
Members of the phospholipase A 2 (PLA 2 ) superfamily were originally discovered as toxic components of snake venoms 5 . These phospholipases have a high proportion of cysteine (more than 10% of all amino acids) and a high prevalence of disulfide bridges 5 . The PLA 2 superfamily is categorized into subgroups on the basis of the number and location of disulfide bridges, with groups I, II and III being originally characterized by phospholipases isolated from cobra, rattlesnake and honeybee venom, respectively (with honeybee PLA 2 being substantially different structurally from the two snake venom PLA 2 phospholipases) 5 . However, all phospholipases of the PLA 2 superfamily share the ability to cleave fatty acids at the sn-2 position of glycerophospholipids, thereby generating free fatty acids and lysophospholipids 5 . The main biological functions of mammalian secreted PLA 2 (sPLA 2 ) phospholipases (groups I, II and III) include but are not limited to the metabolism of dietary phospholipids and contributions to skin homeostasis and host defense against bacteria and viruses 5, 6 (Fig. 1, step 3) .
The PLA 2 phospholipases isolated from certain snake venoms and, with less potency, from honeybee venom, are known to induce antigen-independent degranulation of mouse and human mast cells in vitro 7 (Fig. 1, step 1) . Rat or mouse mast cells also can be activated in vitro by purified rat sPLA 2 of group II 8 . Such group II sPLA 2 phospholipases can be released by mast cells, platelets and other cell types 8, 9 , which raises the possibility of autocrine or paracrine mechanisms of sPLA 2 dependent activation of mast cells in vivo (Fig. 1, steps 2 and 4) . The ability of these sPLA 2 phospholipases to induce mast cell degranulation is reported to depend on their enzymatic activity [7] [8] [9] . However, the systemic toxicity of venom sPLA 2 phospholipases (for example, neurotoxicity) is also thought to be related to the formation of complexes with other toxic venom compounds and their interaction with target molecules expressed in various tissues and organs 10 .
Mammalian PLA2G3 is a multidomain protein with a central PLA 2 domain (150 amino acids) flanked by extensions at the amino terminus (130 amino acids) and carboxyl terminus (219 amino acids) with unknown functions 11 . There is moderate overall amino acid sequence homology between the PLA 2 domain of PLA2G3 and those of sPLA 2 phospholipases from venoms of the Gila monster lizard and the honeybee (46% and 31%, respectively), and relatively high homology for similar comparisons of the conserved calcium-binding loop (73% and 64%, respectively) and active-site regions (54%); therefore, PLA2G3 has been assigned to group III 11 . It has been shown that PLA2G3 potentially contributes to sperm maturation and to the development of atherosclerosis in mice 5, 6 .
Taketomi et al. first show that large amounts of purified honeybee venom PLA 2 and recombinant human PLA2G3 can induce tissue edema in mouse ear pinnae by inducing mast cell degranulation, and they identify PLA2G3 n e w S A n D v I e w S npg volume 14 number 6 June 2013 nature immunology the authors show that Pla2g3 is also expressed in bone marrow-derived mouse basophils but they do not comment on the possible production of PLA2G3 by other hematopoietic cells, such as neutrophils and eosinophils. In this context, the diminished cutaneous anaphylaxis observed in Pla2g3-deficient mice actively sensitized with ovalbumin and alum might also be related to PLA2G3 deficiency in basophils or neutrophils, as the dependence of this model on mast cells alone is not directly tested.
The authors also use a mast cell-fibroblast coculture system to provide an additional line of evidence that PLA2G3 is important for the normal maturation of mast cells. By analyzing various transgenic mouse models in which components of lipid pathways with potential effects on the maturation or function of mast cells (for example, via actions of eicosanoid mediators) 12 are targeted, Taketomi et al. investigate the hypothesis that the observed effects of PLA2G3 on mast cells are associated with the role of PLA2G3 in lipid metabolism 4 . Like Pla2g3 -/-mice, Ptgdr -/-mice, which have systemic deficiency in DP1 (a prostaglandin receptor expressed in several different cell types) or Ptgds -/-mice, which are deficient in L-PGDS (an enzyme expressed by fibroblasts that is involved in synthesis of the prostaglandin PGD 2 ) develop abnormal mast cell phenotypes and attenuated passive cutaneous anaphylaxis. After culture with wild-type fibroblasts, mast cells derived from Ptgdr -/-mice have much less enhancement in the expression of histidine decarboxylase (HDC), an enzyme required for histamine synthesis by mast cells and for the normal formation of cytoplasmic granules. Furthermore, wild-type mast cells cultured with L-PGDS-deficient fibroblasts also have impaired granule formation and lower expression of HDC. Together these findings indicate that the maturational effects of fibroblast L-PGDS require expression of DP1 by mast cells. Finally, the authors provide evidence that this fibroblastassociated, lipid-based mast cell maturation pathway also exists in humans. Specifically, the robust HDC expression observed in human lung mast cells after culture with lung fibroblasts is significantly diminished by neutralization of PLA2G3, L-PGDS or DP1. These novel findings, based on an impressive amount of work, support a model in which PLA2G3 secreted by mast cells (Fig. 1,  step 7 ) induces the expression of fibroblastderived PGD 2 synthase L-PGDS (Fig. 1, step 8) , which leads to enhanced local production of PGD 2 ; this in turn promotes the maturation of mast cells via DP1 (Fig. 1, step 9) .
A notable conclusion of this study is that PLA2G3 not only can activate mast cells (as has been shown before for other mammalian sPLA 2 phospholipases 7,8 ) but also can contribute be cell intrinsic and seems to be related at least in part to the ability of PLA2G3 to promote the normal maturation of mast cell granules (for example, PLA2G3-deficient mast cells have much lower amounts of histamine and granule-stored proteases) and in part to its ability to enhance the abundance of surface FcεRI. These data convincingly identify an important role for mast cell-derived PLA2G3 in the maturation and function of mast cells but do not rule out the possibility of potential contributions of PLA2G3 derived from other cell types. Indeed, as a cytoplasmic (and perhaps granuleassociated) sPLA 2 in mouse mast cells 4 (Fig. 1) . Using mice systemically deficient in Pla2g3 or other sPLA 2 phospholipases, mice that overexpress human PLA2G3 and mast cell-deficient mice engrafted with bone marrow-derived cultured mast cells from various transgenic mouse strains, the authors show that PLA2G3 (but none of the other sPLA 2 phospholipases tested) can contribute to the intensity of IgEand mast cell-dependent passive systemic anaphylaxis in vivo. This effect of PLA2G3 seems to (which can be produced by mast cells) can directly induce mast cell degranulation (4) and can also enhance antigen-and IgE-dependent mast cell degranulation (not shown) 4 . These findings suggest the following model of how PLA2G3 can promote mast cell maturation in peripheral tissues: SCF produced by fibroblasts binds to and induces dimerization of its receptor c-Kit on mast cells (5); signaling via c-Kit enhances mast cell survival and promotes mast cell maturation and, under certain circumstances, also can induce mast cells to secrete PLA2G3 (6); mast cell-secreted PLA2G3 (in the presence of (an) additional, presumably mast cell-derived, factor(s) yet to be identified) interacts with fibroblasts, in a way that remains to be determined (7), and increases expression of the PGD 2 -synthesizing enzyme L-PGDS (8); and fibroblast L-PGDS supplies a local pool of PGD 2 that, by binding to DP1 expressed by mast cells, locally contributes to terminal mast cell maturation (9), including increasing the mast cell's content of cytoplasmic granule-associated mediators, such as histamine and proteases, and also a greater surface abundance of FcεRI (not shown). Such 'maturation effects' prime tissue mast cells to respond more strongly to stimulation with IgE and specific antigen and thus contribute to the intensity of IgE-dependent biological responses (not shown).
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n E w S A n D v I E w S npg of PLA2G3 has an important role in this paracrine interaction pathway, an additional mechanism might involve the direct interaction of PLA2G3's unique amino-or carboxyterminal domains with molecules expressed by fibroblasts or other structural cells 5 . It also will be interesting to determine whether other mast cell-secreted factors provide an important contribution to this process (Fig. 1, step 7) and to assess in detail how features of this axis are influenced by SCF, which can augment the IgE-dependent generation of PGD 2 by mouse mast cells at least in part by upregulating mast cell expression of the three enzymes in the pathway that generates PGD 2 from membrane phospholipids: cPLA 2 , prostaglandin H synthase and hematopoietic PGDS 12 .
The work of Taketomi et al. 4 thus makes important contributions to the understanding of the potential roles of secreted phospholipases and lipid mediators in paracrine and autocrine mechanisms that contribute to the regulation of mast cell development and function.
to the maturation of mast cells in tissues. In this case, the molecule of interest was shown first to be an activator of mast cells and then to be a contributor to mast cell maturation. In contrast, SCF was originally described as a critical factor for the survival and maturation of mast cells, but subsequent studies have shown that SCF can also activate mast cells directly and can enhance IgE-and antigen-dependent activation of mast cells 1, 3 . We are tempted to speculate that such a dual role in enhancing the maturation of mast cells, as well as in certain circumstances in directly inducing and/or enhancing the secretory function of mast cells, might emerge as a feature shared by many mast cell 'maturation factors' .
An obvious goal for future studies is to elucidate in detail the mechanisms that lead to the enhanced production of fibroblast L-PGDS after the release of PLA2G3 from mast cells and, subsequently, to the local generation of PGD 2 that contributes to mast cell maturation. Although it is possible that the enzymatic activity These fascinating observations also suggest that additional findings of interest remain to be provided by the extension of such investigations to other types of hematopoietic cells.
T he production of cells of the immune system is an exceptionally suitable model with which to study the mechanisms that underlie development. Dozens of distinct blood cell types develop from multipotential blood progenitors. The isolation and analysis of developmentally intermediate cells by hundreds of laboratories over the past decades has allowed the construction of a detailed developmental tree (usually drawn inverted, with blood stem cells at the apex and sequential branch lines showing lineage 'choices' from intermediate stages to mature cells of the immune system; Fig. 1 ). In this issue of Nature Immunology, Jojic et al. present a novel computational method, Ontogenet, designed to associate candidate regulators with their gene targets to delineate the gene-regulatory networks that drive differentiation 1 . They apply this algorithm to the publically available gene-expression profiles of 246 cell types of the mouse immune system derived by the Immunological Genome Project (ImmGen) Consortium and build a model that associates 578 candidate regulators with modules of coexpressed genes. The data and tools generated are also available online (http://www.immgen.org/ModsRegs/ modules.html).
The approach taken by Jojic et al. relies on the following assumptions 1 : coexpressed genes are probably controlled by shared transcriptional regulators 2 ; these transcriptional regulators are themselves transcriptionally regulated; and the amount of expression of transcriptional regulators provides information about their activity 3 . When those assumptions hold, it is possible to deduce causal connections between changes in the expression of transcriptional regulators and modules of coexpressed gene targets 4 ( Fig. 1) . Published work has shown that such approaches can indeed be used to delineate simpler regulatory networks 5 . Here, application to a more complex regulatory network is accomplished, which provides a new framework for understanding other developmental and differentiation networks. As the authors describe, the Ontogenet program receives as input modules of coexpressed genes and their expression profiles, the expression profiles of a predesignated set of 'candidate regulators' from every hematopoietic cell population, and the lineage tree of hematopoiesis describing the relationships between each of these populations. The algorithm associates each module with a set of candidate regulators whose expression best explains the expression pattern of the module across hematopoietic development. Using this method, Jojic et al. identify many known hematopoietic regulators and also predict additional roles for 175 candidate regulators 1 . This is perhaps a surprise, given the well-studied nature of hematopoiesis, and suggests that earlier approaches to understanding transcriptional regulation in hematopoiesis may have missed important events.
The assumption by Jojic et al. that coexpressed genes are probably controlled by common transcriptional regulators 1 follows a n E w S A n D v I E w S npg
